BUCHI J KEVIN 4
4 · Amneal Pharmaceuticals, Inc. · Filed May 8, 2025
Insider Transaction Report
Form 4
BUCHI J KEVIN
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-05-05−40,258→ 0 total→ Class A Common Stock (40,258 underlying) - Exercise/Conversion
Class A Common Stock
2025-05-05+40,258→ 40,258 total - Award
Restricted Stock Units
2025-05-06+34,819→ 34,819 total→ Class A Common Stock (34,819 underlying)
Holdings
- 262,072(indirect: By Trust)
Class A Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.
- [F3]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.